GGrantIndex
← Leaderboards

Wadie F Bahou

State University New York Stony Brook

$11,754,670
Attributed
$14,022,360
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,536,480 · 11

By mechanism

R01$10,563,749 · 5
TL1$3,023,587 · 1
U2C$1,514,120 · 1
R21$415,560 · 1
M01$19,464 · 3

Most similar at State University New York Stony Brook

Same institution · by research overlap

Others in their field

Top investigators on “Grant

Research focus

GrantBlood PlateletsMegakaryocytesPhenotypePathway InteractionsFundingEquilibriumProgramsAffectInterdisciplinary CollaborationGeneticMolecularResearch PersonnelCohortInstitutionCellsMethodologyCoagulation ProcessAnimal ModelCollaborationsGenesHemorrhageThrombosisHemostatic Function

Grant awards (38)

New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$651,894
TL1 · FY2025 · DK
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$56,301
TL1 · FY2025 · DK
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$579,682
TL1 · FY2024 · DK
Molecular characterization of biliverdin IXbeta reductase$483,137
R01 · FY2024 · HL · contact PI
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$469,899
U2C · FY2024 · DK
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$55,692
TL1 · FY2024 · DK
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$822,962
TL1 · FY2023 · DK
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$522,110
U2C · FY2023 · DK
Molecular characterization of biliverdin IXbeta reductase$492,998
R01 · FY2023 · HL · contact PI
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$53,810
TL1 · FY2023 · DK
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$803,246
TL1 · FY2022 · DK
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$522,111
U2C · FY2022 · DK
Molecular characterization of biliverdin IXbeta reductase$492,998
R01 · FY2022 · HL · contact PI
Molecular characterization of biliverdin IXbeta reductase$492,998
R01 · FY2021 · HL · contact PI
Platelet Systems Biology in Health and Disease$695,631
R01 · FY2019 · HL · contact PI
Platelet Systems Biology in Health and Disease$695,631
R01 · FY2018 · HL · contact PI
Platelet Systems Biology in Health and Disease$695,631
R01 · FY2017 · HL · contact PI
Platelet Systems Biology in Health and Disease$695,631
R01 · FY2016 · HL · contact PI
Platelet Systems Biology in Health and Disease$695,631
R01 · FY2015 · HL · contact PI
Genetic dissection of the platelet thrombohemorrhagic phenotype$388,575
R01 · FY2012 · HL · contact PI
Genetic dissection of the platelet thrombohemorrhagic phenotype$392,500
R01 · FY2011 · HL · contact PI
Genetic dissection of the platelet thrombohemorrhagic phenotype$392,084
R01 · FY2010 · HL · contact PI
Genetic dissection of the platelet thrombohemorrhagic phenotype$390,000
R01 · FY2009 · HL · contact PI
EFFECT OF ASPIRIN ON PLATELET AND MEGAKARYOCYTE GENE PROFILES$8,446
M01 · FY2009 · RR · contact PI
MOLECULAR BASIS OF ESSENTIAL THROMBOCYTOSIS$5,479
M01 · FY2009 · RR · contact PI
Molecular characterization of a thrombin receptor$321,078
R01 · FY2007 · HL · contact PI
Integrated molecular profiling of the platelet thrombohemorrhagic phenotype$150,505
R21 · FY2007 · HL · contact PI
MOLECULAR BASIS OF ESSENTIAL THROMBOCYTOSIS$5,539
M01 · FY2007 · RR · contact PI
Molecular characterization of a thrombin receptor$330,668
R01 · FY2006 · HL · contact PI
Molecular profiling of the platelet thrombohemorrhagic$265,055
R21 · FY2006 · HL · contact PI
Molecular characterization of a thrombin receptor$328,525
R01 · FY2005 · HL
Molecular characterization of a thrombin receptor$301,000
R01 · FY2004 · HL
TARGETED GENE THERAPY FOR HEMOPHILIA A$486,335
R01 · FY2003 · HL
TARGETED GENE THERAPY FOR HEMOPHILIA A$479,015
R01 · FY2002 · HL
TARGETED GENE THERAPY FOR HEMOPHILIA A$439,809
R01 · FY2001 · HL
MOLECULAR CHARACTERIZATION OF THROMBIN RECEPTOR$254,827
R01 · FY2001 · HL
TARGETED GENE THERAPY FOR HEMOPHILIA A$371,639
R01 · FY2000 · HL
MOLECULAR CHARACTERIZATION OF THROMBIN RECEPTOR$247,408
R01 · FY2000 · HL